[1]Noyce,D.S.;Fike,S.A.[JournalofOrganicChemistry,1973,vol.38,p.3316-3318]
[2]CurrentPatentAssignee:NEUROCRINEBIOSCIENCESINC-WO2005/97093,2005,A1Locationinpatent:Page/Pagecolumn65
71670-79-6
3364-78-1
38373-55-6 | 2-Benzylamino-5-bromopyrimidine | AA00CJWP | MFCD00483264
32265-50-2 | 5,6-Dichloro-2-methyl-4-pyrimidinol | AA00CK0V | MFCD12025845
39131-44-7 | 5-(bromomethyl)-2-furaldehyde | AA00CKGA | MFCD15832881
3347-99-7 | 4-Methylisophthalic acid | AA00CKSI | MFCD09878876
343270-47-3 | 2-Methyl-1-(3-pyridyl)-1-propylamine | AA00CKY1 | MFCD09971213
359779-74-1 | tert-Butyl 3-oxo-6-azabicyclo[3.2.1]octane-6-carboxylate | AA00CLBC | MFCD17016765
400746-75-0 | 2-(4-Benzyloxyphenyl)aniline | AA00CLKT | MFCD04039047
385378-70-1 | 4-bromo-N-(2-chloroethyl)benzenesulfonamide | AA00CLQ6 | MFCD00666093
32822-84-7 | Methyl 3-hydroxy-4,5-dimethylthiophene-2-carboxylate | AA00CLUR | MFCD15071706
40632-26-6 | Cytarabine-d2 | AA00CM3E | MFCD12022182